Experimental Dermatology
Impact of VDR and RXR expression in non‐melanoma skin cancer pathogenesis
Experimental Dermatology, Volume 31, Issue 8, Page 1202-1207, August 2022.
Experimental Dermatology
The neuropeptide Substance P facilitates the transition from an inflammatory to proliferation phase‐associated responses in dermal fibroblasts
Experimental Dermatology, Volume 31, Issue 8, Page 1188-1201, August 2022.
Experimental Dermatology
Secretomes as an emerging class of bioactive ingredients for enhanced cosmeceutical applications
Experimental Dermatology, Accepted Article.
Experimental Dermatology
Functional investigation of two simultaneous or separately segregating DSP variants within a single family supports the theory of a dose‐dependent disease severity
Experimental Dermatology, Volume 31, Issue 6, Page 970-979, June 2022.
Experimental Dermatology
Tiered approach for evaluation of anti‐melanogenic activity of trans‐N‐coumaroyltyramine derivatives
Experimental Dermatology, Volume 31, Issue 8, Page 1177-1187, August 2022.
Experimental Dermatology
Ultraviolet light induces HERV expression to activate RIG‐I signalling pathway in keratinocytes
Experimental Dermatology, Volume 31, Issue 8, Page 1165-1176, August 2022.
Experimental Dermatology
PP2Acα regulates epidermal cell proliferation via the EGFR/AKT/mTOR pathway in psoriasis‐like skin lesions caused by PPP2CA deficiency
Experimental Dermatology, Volume 31, Issue 8, Page 1154-1164, August 2022.
Experimental Dermatology
Whole‐transcriptome sequencing identifies postzygotic ATP2A2 mutations in a patient misdiagnosed with herpes zoster, confirming the diagnosis of very late‐onset segmental Darier disease
Experimental Dermatology, Volume 31, Issue 6, Page 943-948, June 2022.
Experimental Dermatology
Suppression of IL‐12/IL‐23 p40 subunit in the skin and blood of psoriasis patients by Tofacitinib is dependent on active interferon‐γ signaling in dendritic cells: Implications for the treatment of psoriasis and interferon‐driven diseases
Experimental Dermatology, Volume 31, Issue 6, Page 962-969, June 2022.
Experimental Dermatology
Different levels of EGF, VEGF, IL‐6, MCP‐1, MCP‐3, IP‐10, Eotaxin and MIP‐1α in the adipose‐derived stem cell secretome in androgenetic alopecia
Experimental Dermatology, Volume 31, Issue 6, Page 936-942, June 2022.